Hay Fever News and Research

RSS
Hay fever (pollen allergy) is one of the most common kinds of allergies. About 35 million Americans suffer from hay fever. Pollen is made by trees, grasses, and weeds. During the spring, summer, and fall some plants release pollen into the air you breathe. Your symptoms might be different at different times of the year. It all depends on the kinds of plants that grow where you live and what allergies you have.
AstraZeneca enters agreement with Pfizer for OTC NEXIUM

AstraZeneca enters agreement with Pfizer for OTC NEXIUM

Common ragweed may induce airways irritation through terpenoids

Common ragweed may induce airways irritation through terpenoids

TAU research identifies protein group that may kick-start allergic reactions

TAU research identifies protein group that may kick-start allergic reactions

Sunovion launches ZETONNA Nasal Aerosol for allergic rhinitis

Sunovion launches ZETONNA Nasal Aerosol for allergic rhinitis

Hay fever symptom severity plateau identified

Hay fever symptom severity plateau identified

Latest allergy research presented at EAACI Congress 2012

Latest allergy research presented at EAACI Congress 2012

Hay fever vaccine shows efficacy in phase IIa trial

Hay fever vaccine shows efficacy in phase IIa trial

European study on allergies investigates birch, olive and grass pollens

European study on allergies investigates birch, olive and grass pollens

Allergies may provide benefit by keeping away noxious environmental toxins

Allergies may provide benefit by keeping away noxious environmental toxins

Study: Sharp increase in airborne pollens across Europe

Study: Sharp increase in airborne pollens across Europe

ACAAI to conduct 16th annual Nationwide Asthma Screening Program

ACAAI to conduct 16th annual Nationwide Asthma Screening Program

FDA approves Teva's QNASL nasal aerosol corticosteroid

FDA approves Teva's QNASL nasal aerosol corticosteroid

Allergy season comes early with high pollen counts

Allergy season comes early with high pollen counts

AAFA releases new 'Spring Allergy Capital' rankings

AAFA releases new 'Spring Allergy Capital' rankings

Meda announces positive results from three MP29-02 studies on allergic rhinitis

Meda announces positive results from three MP29-02 studies on allergic rhinitis

NAET safe and effective in treating children with allergy-related autism

NAET safe and effective in treating children with allergy-related autism

New First Choice infographic explores issue of SAD and winter blues

New First Choice infographic explores issue of SAD and winter blues

Sunovion reports positive results from ciclesonide nasal aerosol Phase III study for perennial allergic rhinitis

Sunovion reports positive results from ciclesonide nasal aerosol Phase III study for perennial allergic rhinitis

Reduced diversity of intestinal microbiota associated with increased risk of allergic disease

Reduced diversity of intestinal microbiota associated with increased risk of allergic disease

Winter health and safety tips

Winter health and safety tips